Cas:1072951-68-8 (3,5-Diformyl-2-isopropoxyphenyl)boronic acid manufacturer & supplier

Chemical Name:(3,5-Diformyl-2-isopropoxyphenyl)boronic acid

CAS.NO:1072951-68-8

Synonyms:(3,5-diformyl-2-propan-2-yloxyphenyl)boronic acid

Molecular Formula:C₁₁H₁₃BO₅

Molecular Weight:236.02900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:83.83000

Exact Mass:236.08600

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (3,5-diformyl-2-propan-2-yloxyphenyl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3,5-diformyl-2-propan-2-yloxyphenyl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3,5-diformyl-2-propan-2-yloxyphenyl)boronic acid Use and application,(3,5-diformyl-2-propan-2-yloxyphenyl)boronic acid technical grade,usp/ep/jp grade.

Related News: Like SARS, this latest outbreak is caused by a coronavirus, a family of viruses common to animals that range from the common cold, to more serious diseases, like Middle East respiratory syndrome (MERS). (3,5-Diformyl-2-isopropoxyphenyl)boronic acid manufacturer An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. (3,5-Diformyl-2-isopropoxyphenyl)boronic acid supplier Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed. (3,5-Diformyl-2-isopropoxyphenyl)boronic acid vendor Like SARS, this latest outbreak is caused by a coronavirus, a family of viruses common to animals that range from the common cold, to more serious diseases, like Middle East respiratory syndrome (MERS). (3,5-Diformyl-2-isopropoxyphenyl)boronic acid factory China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price.